Register for OBR daily

Kantar Health Conference Sidebar

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

RNN $0.73 0.0680 +10.27%
IMNP $3.79 0.2900 +8.29%
MRTX $18.07 1.3200 +7.88%
CBMG $18.40 1.2850 +7.51%
MGNX $20.15 1.3000 +6.90%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

TGTX $8.26 -1.3350 -13.92%
VRML $2.37 -0.1300 -5.20%
GERN $2.59 -0.1300 -4.78%
CNDO $1.64 -0.0600 -3.53%
CTIC $2.66 -0.0800 -2.92%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | Next > | Last >>

New Drug Policy Too Burdensome, Hospices Say

(Reuters Health) June 26, 2014 - The Centers for Medicare and Medicaid Services met Wednesday with 30 hospice and healthcare organizations after outcry over a new rule. The rule was designed to help avoid duplicate payments for hospice medications but may be having unintended consequences.
read article 

Janssen Submits EU Marketing Application for VELCADE (bortezomib) in Mantle Cell Lymphoma

(MarketWatch) June 27, 2014 - Type II variation submitted to the European Medicines Agency to expand current VELCADE label to include previously untreated patients with Mantle Cell Lymphoma.
read article 

CNIO Researchers Discover More Than 40 Melanoma-Specific Genes That Determine Aggressiveness

(Science Codex) June 27, 2014 - Researchers from the Spanish National Cancer Research Centre (CNIO) have discovered more than 40 genes that predict the level of aggressiveness of melanoma and that distinguish it from other cancers with a poor prognosis.
read article 

Some Aggressive Cancers May Respond to Anti-Inflammatory Drugs

(WUSTL) June 26, 2014 - New research raises the prospect that some cancer patients with aggressive tumors may benefit from a class of anti-inflammatory drugs used to treat rheumatoid arthritis.
read article 

Dartmouth Researchers Conduct Comprehensive Review of Treatments for Depression in Cancer Patients

(Norris Cotton Cancer Center/Dartmouth) June 26, 2014 - Depression is common in cancer, up to half of all patients facing the disease experience depressive symptoms, ranging from mild to severe. When depression co-exists with cancer, patients may be at an increased risk of death from cancer and from suicide.
read press release 

Scripps Research Institute Scientists Find Potential New Use For Cancer Drug in Gene Therapy for Blood Disorders

(TSRI) June 26, 2014 - Scientists working to make gene therapy a reality have solved a major hurdle: how to bypass a blood stem cell’s natural defenses and efficiently insert disease-fighting genes into the cell’s genome.
read press release 

Survival Up After Progression in HPV-Positive Oropharynx CA

(Doctors Lounge/HealthDay News) June 26, 2014 - For patients with oropharynx cancer, human papillomavirus positivity is associated with improved survival after disease progression, according to a study published online June 23 in the Journal of Clinical Oncology.
read article 

18F-FGD-PET Measures Predict mRCC TKI Response

(medwireNews) June 27, 2014 - Positron emission tomography (PET) could be used to predict the response of metastatic renal cell carcinoma (mRCC) to tyrosine kinase inhibitor (TKI) therapy within a couple of weeks of a patient beginning treatment, research suggests.
read article 

Study Points to Higher Risk of Breast Cancer Progression in Obese Women

(MD Anderson) June 27, 2014 - Scientists have long believed that obese women who developed estrogen-positive (ER+) breast cancer were at higher risk for death from the illness than lean women with the same diagnosis.
read press release 

Breast Cancer Drug Hope From Leukaemia Research

(BBC News) June 26, 2014 - Leukaemia research may lead to new drugs for difficult-to-treat breast cancers, say scientists.
read article 

Regorafenib From Bayer Recommended for Approval in the European Union for the Treatment of Gastrointestinal Stromal Tumors

(Bayer HealthCare) June 27, 2014 – The oncology compound regorafenib (Stivarga) from Bayer has been recommended for approval by the European Committee for Medicinal Products for Human Use (CHMP) for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumors (GIST) who progressed on or are intolerant to prior treatment with imatinib and sunitinib.
read corporate press release 

CHMP Backs Use of Avastin for Hard-to-Treat Ovarian Cancer

(Pharma Times [UK]) June 27, 2014 - Advisors to the European Medicines Agency have backed Roche’s blockbuster Avastin for the most difficult to treat form of ovarian cancer.
read article 

CHMP Recommends EU Approval of Roche’s Avastin for Platinum-Resistant Recurrent Ovarian Cancer

(Roche) June 27, 2014 - Roche announced today that the EU Committee for Medicinal Products for Human Use (CHMP) recommended that the European Commission approve the use of Avastin (bevacizumab) in combination with chemotherapy as a treatment for women with ovarian cancer that is resistant to platinum-containing chemotherapy.
read corporate press release 

NICE U-Turn on Novartis' Glivec in GIST

(Pharma Times [UK]) June 26, 2014 - In a U-turn from previous guidance, the National Institute for Health and Care Excellence is now planning to recommend National Health Service use of Novartis' Glivec (imatinib) for the treatment of digestive system tumours.
read article 

Blood Test Could Give Early Warning of Breast Cancer

(The Guardian/Press Association [UK]) June 26, 2014 - A simple blood test could offer many women an early warning of breast cancer even if they do not inherit genes linked to the disease. Scientists have identified a molecular "switch" in blood samples that increases a woman's chances of having breast cancer.
read article 

Some Liver-Transplant Patients Able to Stop Taking Immunosuppressants, Study Finds

(Wall Street Journal) June 25, 2014 - A small but intriguing new study found that some people with hepatitis C who underwent a liver transplant were eventually able to stop taking immunosuppressant drugs designed to keep the recipient from rejecting the new organ.
read article (paid subscription required) 

Closer Look at Gilead's Slowing Hep C Prescriptions

(TheStreet) June 26, 2014 - Is a slowdown in Sovaldi prescriptions the beginning of the highly anticipated "re-warehousing" of patients, or is some other factor at play?
read article 

Stakes Rising for Shire as AbbVie Makes Its Case for Buying the Drug Maker

(MarketWatch/Health Exchange blog) June 25, 2014 - The stakes are rising for Shire PLC, as rejected suitor AbbVie Inc. has come back with a treatise on why it should partner with the Irish drug maker and it isn’t ruling out the possibility of a hostile takeover.
read article 

Hospital Outpatient Prices Sharply Higher Than Docs', Study Finds

( June 26, 2014 - Hospital outpatient prices for standard blood tests, cancer screening and other services varied widely and were sharply higher, on average, than prices charged by ambulatory clinics and independent doctors, an analysis of autoworker health-plan spending across 18 cities has found.
read article (free registration required) 

U.S. Healthcare Profit Outlook Brightens on Obamacare, Drug Prices

(Reuters) June 26, 2014 - U.S. healthcare companies are winning higher profit forecasts, bucking a wider trend on Wall Street, as pricey new biotech drugs hit the market and insurance enrollment rises under the Affordable Care Act.
read article 

FDA Gives Controversial Doc Green Light to Restart Work

(USA Today) June 25, 2014 - The Food and Drug Administration has given a controversial Houston doctor the green light to resume administering experimental cancer treatments.
read article 

Letters: Women, Non-Smokers and Lung Cancer Screening Cost

(Wall Street Journal) June 25, 2014 - A large study of 53,000 individuals demonstrated a 20% reduction in lung-cancer mortality, although this represented fewer than 100 additional lives saved.
read article (paid subscription required) 

Barnholtz-Sloan to Chair Neuro-Oncology Initiative for Ohio Clinical Trials Collaborative

(4-traders) June 26, 2014 - The Ohio Clinical Trials Collaborative (OCTC) has appointed Jill Barnholtz-Sloan, PhD, as Chair of its Neuro-Oncology Working Group.
read article 

Pancreatic Cancer Research Center Takes Transformative Approach

(MSKCC/OnCancer blog) June 26, 2014 – Memorial Sloan Kettering has launched the David M. Rubenstein Center for Pancreatic Cancer Research (CPCR).
read article 

Foundation Medicine Offers FoundationOne CareLine to Provide Personalized Assistance to Cancer Patients Seeking Access to Targeted Therapies

(Yahoo! Finance) June 26, 2014 - Foundation Medicine, Inc. today announced that it has partnered with Patient Advocate Foundation (PAF) on a national program to provide assistance to patients with cancer and their families seeking access to targeted therapies.
read article